ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccineMerck's 3-pronged cancer strategy stars Moderna-partnered vaccine - Fierce Biotech fiercebiotech.com Submitted by fiercebiotech9600 on June 4, 2024 at 9:11 PM in business No comments 27